SEC Form 4 · accession 0001127602-19-008800
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 9:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | M | 25,123 | $73.70 | A | 306,494 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.33 | D | 306,394 | D | |
| Common Stock | Feb 26, 2019 | S | 500 | $139.34 | D | 305,894 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.43 | D | 305,794 | D | |
| Common Stock | Feb 26, 2019 | S | 53 | $139.44 | D | 305,741 | D | |
| Common Stock | Feb 26, 2019 | S | 147 | $139.45 | D | 305,594 | D | |
| Common Stock | Feb 26, 2019 | S | 400 | $139.46 | D | 305,194 | D | |
| Common Stock | Feb 26, 2019 | S | 38 | $139.49 | D | 305,156 | D | |
| Common Stock | Feb 26, 2019 | S | 345 | $139.51 | D | 304,811 | D | |
| Common Stock | Feb 26, 2019 | S | 300 | $139.52 | D | 304,511 | D | |
| Common Stock | Feb 26, 2019 | S | 200 | $139.54 | D | 304,311 | D | |
| Common Stock | Feb 26, 2019 | S | 30 | $139.55 | D | 304,281 | D | |
| Common Stock | Feb 26, 2019 | S | 171 | $139.56 | D | 304,110 | D | |
| Common Stock | Feb 26, 2019 | S | 177 | $139.57 | D | 303,933 | D | |
| Common Stock | Feb 26, 2019 | S | 99 | $139.58 | D | 303,834 | D | |
| Common Stock | Feb 26, 2019 | S | 605 | $139.59 | D | 303,229 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.595 | D | 303,129 | D | |
| Common Stock | Feb 26, 2019 | S | 210 | $139.60 | D | 302,919 | D | |
| Common Stock | Feb 26, 2019 | S | 200 | $139.61 | D | 302,719 | D | |
| Common Stock | Feb 26, 2019 | S | 30 | $139.62 | D | 302,689 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.625 | D | 302,589 | D | |
| Common Stock | Feb 26, 2019 | S | 130 | $139.63 | D | 302,459 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.635 | D | 302,359 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $73.70 | Feb 26, 2019 | M | 25,123 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 25,123 | 25,124 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.